MediPharm Labs Corp. ( MEDIF) - Stock Earnings

MEDIF Quarterly earnings

DateEarningsRevenue
2025Q3 — USD 12.2 million USD
2025Q4 — USD 11.1 million USD
2026Q1 — CAD 9.0 million CAD

MEDIF Yearly earnings

Analyst consensus estimates are available to paid members.

DateEarningsRevenue
2023 -17.4 million USD 33.1 million USD
2024 — USD 42.0 million USD
2025 — USD 45.1 million USD
2026 Est.

MEDIF

Price: $0.06

52 week price:
0.04
0.08

Earnings Per Share: -0.03 USD

P/E Ratio: -1.83

Exchange: OQB

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Market Capitalization: 26.7 million

Links: